Related Experiment Video
Updated: Feb 25, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in
Paolo Preziosa1,2, Elisabetta Pagani1, Sarlota Mesaros3
1Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Abstract:
In this longitudinal study, we investigated the regional patterns of focal lesions accumulation, and gray (GM) and white matter (WM) atrophy progression over a five-year follow-up (FU) in multiple sclerosis (MS) patients and their association with clinical and cognitive deterioration. Neurological, neuropsychological and brain MRI (dual-echo and 3D T1-weighted sequences) assessments were prospectively performed at baseline (T0) and after a median FU of 4.9 years from 66 MS patients (including relapse-onset and primary progressive MS) and 16 matched controls. Lesion probability maps were obtained. Longitudinal changes of GM and WM volumes and their association with clinical and cognitive deterioration were assessed using tensor-based morphometry and SPM12. At FU, 36/66 (54.5%) MS patients showed a significant disability worsening, 14/66 (21.2%) evolved to a worse clinical phenotype, and 18/63 (28.6%) developed cognitive deterioration. At T0, compared to controls, MS patients showed a widespread pattern of GM atrophy, involving cortex, deep GM and cerebellum, and atrophy of the majority of WM tracts, which further progressed at FU (P < 0.001, uncorrected). Compared to stable patients, those with clinical and cognitive worsening showed a left-lateralized pattern of GM and WM atrophy, involving deep GM, fronto-temporo-parieto-occipital regions, cerebellum, and several WM tracts (P < 0.001, uncorrected).GM and WM atrophy of relevant brain regions occur in MS after 5 years. A different vulnerability of the two brain hemispheres to irreversible structural damage may be among the factors contributing to clinical and cognitive worsening in these patients. Hum Brain Mapp 38:5648-5665, 2017. © 2017 Wiley Periodicals, Inc.
Insights
Multiple sclerosis patients show significant gray and white matter atrophy over five years, linked to worsening disability and cognition. A left-hemisphere vulnerability may drive these clinical declines.
Area of Science:
- Neuroimaging
- Neurology
- Brain Research
Background:
- Multiple sclerosis (MS) is a chronic demyelinating disease characterized by focal lesions and progressive neurodegeneration.
- Understanding the longitudinal patterns of brain atrophy and their clinical correlations is crucial for MS management.
Purpose of the Study:
- To investigate regional gray matter (GM) and white matter (WM) atrophy progression over five years in MS patients.
- To associate these structural changes with clinical and cognitive deterioration.
Main Methods:
- Longitudinal study with 66 MS patients and 16 controls, assessed at baseline and after a median 4.9-year follow-up.
- Brain MRI (dual-echo, 3D T1-weighted) and neurological/neuropsychological assessments.
- Analysis using lesion probability maps, tensor-based morphometry, and SPM12.
Main Results:
- At follow-up, 54.5% of MS patients showed worsening disability, 21.2% evolved to a worse clinical phenotype, and 28.6% experienced cognitive decline.
- MS patients exhibited widespread GM and WM atrophy at baseline, progressing significantly over five years.
- Patients with clinical and cognitive worsening displayed a left-lateralized pattern of GM and WM atrophy.
Conclusions:
- Significant GM and WM atrophy occurs in MS patients within five years.
- A differential vulnerability of brain hemispheres to structural damage may contribute to clinical and cognitive worsening in MS.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Overview
Cognitive Development During Adulthood
Alzheimer's Disease: Treatment

